Glucose News and Research

RSS

Omega-3 fatty acids may provide more benefits for elderly people with Alzheimer's

According to a recent study published online in Neurology, Omega-3 fatty acids, like those found in Omega XL fish oil extract containing DHA and EPA from the New Zealand green-lipped mussel, may provide more benefits for elderly people suffering from Alzheimer's.

24 May 2012

Glytec receives FDA clearance for Glucommander 2.0 Enterprise software

Glytec, LLC, headquartered in Greenville, SC, announced today that its Glucommander 2.0 Enterprise software has been cleared by the FDA for pediatric use, ages 2 - 17.

22 May 2012

Medtronic fourth quarter revenue increases 4% to $4.297 billion

Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 27, 2012.

From Medtronic 22 May 2012

Gattex may represent new treatment approach for short bowel syndrome

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported the presentation of data at the Digestive Disease Week (DDW) meeting held May 19-22 in San Diego.

22 May 2012

Strong link between birth weight and glucose metabolism in old age

Small babies had significantly higher blood glucose and insulin levels and a higher risk of diabetes at the age of 75 and older. The risk of diabetes in old age was five-fold among those born small but who were obese in midlife compared to those with higher birth weight and low body mass index in adulthood.

21 May 2012

The Patient Status Engine™ – Industry’s First Cloud-Based Wireless Sensor Vigilance System for Real-time and Predictive Patient Status – Introduced by Isansys

Isansys Lifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces the introduction of its Patient Status Engine™ – the first cloud-based patient digitization and analytic solution for monitoring and predicting the present and future clinical status of patients anytime, anywhere. The introduction of the Patient Status Engine provides the platform for Isansys’ “Vitals as a Service™” solution, which is now offered for priority beta deployments in hospitals and other healthcare facilities.

From Isansys Lifecare Ltd. 21 May 2012

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.

21 May 2012

Regular eating times, extended daily fasting may prevent diabetes, obesity

It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override the adverse health effects of a high-fat diet and prevent obesity, diabetes and liver disease in mice.

18 May 2012

Insight into why diabetics suffer from increased pain and temperature sensitivity

Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.

17 May 2012

Paper-based diabetes device can be adapted for other applications

With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.

17 May 2012

WHO releases World Health Statistics 2012 with first-time data on blood pressure, diabetes

The WHO on Wednesday released its World Health Statistics 2012 report, which "for the first time includes a look at blood pressure and glucose levels, two of the risk factors for diabetes and cardiovascular disease," according to the Associated Press/Washington Post.

17 May 2012

World health statistics 2012 report puts spotlight on growing problem of NCD burden

The World health statistics 2012 report, released today, puts the spotlight on the growing problem of the noncommunicable diseases burden.

16 May 2012

Shengtai third quarter net sales decrease 4.52% to $39,803,608

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the third quarter of fiscal 2012 ended March 31, 2012.

16 May 2012

New hormone link between obesity and type 2 diabetes

A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.

16 May 2012

Latest research on caring for ischemic stroke patients

Following a stroke, factors as varied as blood sugar, body temperature and position in bed can affect patient outcomes, Loyola University Medical Center researchers report.

15 May 2012

Excess protein in urine test predicts renal failure in patients with severe sepsis

Henry Ford Hospital researchers have found that the presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis.

14 May 2012

First U.S. outpatient trial of UVA-developed artificial pancreas

The University of Virginia School of Medicine has launched the first U.S. outpatient trial of a UVA-developed artificial pancreas that could make it easier for type 1 diabetes patients to manage their condition.

14 May 2012

mTOR protein plays a key role in development of diabetes

The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes. In the current issue of the journal Cell Metabolism, Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.

14 May 2012

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.

14 May 2012

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

People with Type 2 diabetes are usually advised to keep a low-fat diet. Now, a study at Linköping University shows that food with a lot of fat and few carbohydrates could have a better effect on blood sugar levels and blood lipids.

11 May 2012

Glucose News and Research

Omega-3 fatty acids may provide more benefits for elderly people with Alzheimer's

Glytec receives FDA clearance for Glucommander 2.0 Enterprise software

Medtronic fourth quarter revenue increases 4% to $4.297 billion

Gattex may represent new treatment approach for short bowel syndrome

Strong link between birth weight and glucose metabolism in old age

The Patient Status Engine™ – Industry’s First Cloud-Based Wireless Sensor Vigilance System for Real-time and Predictive Patient Status – Introduced by Isansys

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

Regular eating times, extended daily fasting may prevent diabetes, obesity

Insight into why diabetics suffer from increased pain and temperature sensitivity

Paper-based diabetes device can be adapted for other applications

WHO releases World Health Statistics 2012 with first-time data on blood pressure, diabetes

World health statistics 2012 report puts spotlight on growing problem of NCD burden

Shengtai third quarter net sales decrease 4.52% to $39,803,608

New hormone link between obesity and type 2 diabetes

Latest research on caring for ischemic stroke patients

Excess protein in urine test predicts renal failure in patients with severe sepsis

First U.S. outpatient trial of UVA-developed artificial pancreas

mTOR protein plays a key role in development of diabetes

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Lot of fat and few carbohydrates could have better effect on blood sugar levels, lipids in diabetics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News